Literature DB >> 20370335

A case of rapid progression and vision loss in a patient with primary intraocular lymphoma.

Amit Sangave1, Lisa J Faia, Steven Yeh, Chi-Chao Chan, Robert B Nussenblatt, H Nida Sen.   

Abstract

PURPOSE: To describe an atypical case of primary intraocular lymphoma (PIOL) with rapid progression leading to vision loss and death.
METHODS: A 71-year-old woman with a history of PIOL presented with a sudden decline in vision. MRI, CSF cytology, and ocular examination 2 months prior were unremarkable.
RESULTS: Repeat MRI of the brain and orbits at this time revealed a 0.8 x 2.4-cm lesion of the left choroid plexus. LP revealed rare atypical B cells. The patient rapidly deteriorated and died a month later.
CONCLUSION: Recognition of the potential for rapid progression and mortality in patients with PIOL is essential.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20370335      PMCID: PMC2923390          DOI: 10.3109/09273940903370748

Source DB:  PubMed          Journal:  Ocul Immunol Inflamm        ISSN: 0927-3948            Impact factor:   3.070


  4 in total

Review 1.  Variations in the presentation of primary intraocular lymphoma: case reports and a review.

Authors:  M K Gill; L M Jampol
Journal:  Surv Ophthalmol       Date:  2001 May-Jun       Impact factor: 6.048

2.  Intraocular lymphoma 2000-2005: results of a retrospective multicentre trial.

Authors:  Kristoph Jahnke; Agnieszka Korfel; Julia Komm; Nikolaos E Bechrakis; Harald Stein; Eckhard Thiel; Sarah E Coupland
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-10-16       Impact factor: 3.117

3.  Increasing incidence of primary brain lymphoma in the US.

Authors:  N L Eby; S Grufferman; C M Flannelly; S C Schold; F S Vogel; P C Burger
Journal:  Cancer       Date:  1988-12-01       Impact factor: 6.860

4.  Primary intraocular lymphoma: an International Primary Central Nervous System Lymphoma Collaborative Group Report.

Authors:  S A Grimm; J S Pulido; K Jahnke; D Schiff; A J Hall; T N Shenkier; T Siegal; N D Doolittle; T Batchelor; U Herrlinger; E A Neuwelt; N Laperriere; M C Chamberlain; J Y Blay; A J M Ferreri; A M P Omuro; E Thiel; L E Abrey
Journal:  Ann Oncol       Date:  2007-09-05       Impact factor: 32.976

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.